| Code | 0417E | ||||||||||
| MA number | EU/1/22/1631/001 | ||||||||||
| Product Form: | dis inf 1-4x4,6 ml (liek.inj.COC) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Bristol-Myers Squibb Pharma EEIG , Ireland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 13 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 04.04.2022 |
| Validity: | 04.04.2027 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | No |
| Data update: | 24.01.2025 |
